Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Twist Bioscience has raised $250.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2022.
Twist Bioscience's investors include ARCH Venture Partners, Cormorant Asset Management, Foresite Capital, Fidelity, Illumina Ventures.
Twist Bioscience is headquartered in San Francisco, United States.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Twist Bioscience is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Twist Bioscience — Funding & Investors." VCBacked, February 9, 2022, https://www.vcbacked.co/company/twist-bioscience. Accessed July 19, 2026.
VCBacked. (2022). Twist Bioscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/twist-bioscience
{{cite web |title=Twist Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/twist-bioscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated